From: The Malaria in Pregnancy Library: a bibliometric review
Indicator of pregnancy | n | % | Indicator of malaria | n | % |
---|---|---|---|---|---|
Pregnant* (Trimester, gestation, HCG, risk group or vulnerable group withreference to pregnancy) | 1,824 | 64.2 | Malaria | 2,241 | 78.9 |
Placenta | 505 | 17.8 | P. falciparum | 555 | 19.5 |
Congenital | 220 | 7.7 | P. vivax | 42 | 1.5 |
Birth (birth weight, birth outcome, childbirth, stillbirth, abortion, delivery,parturition, premature, preterm, newborn, neonatal, child-bearing) | 195 | 6.9 | Other species | 47 | 1.7 |
Maternal | 183 | 6.4 | Anti-malarial (either word or anti-malarialdrug) | 451 | 15.9 |
IPTp | 162 | 5.7 | ITN or net | 82 | 2.9 |
Foetus/foetal (Embryo, developmental toxicity, offspring, reproductivetoxicity, teratogenic, in utero, trophoblast) | 149 | 5.2 | Insecticide | 46 | 1.6 |
Antenatal/prenatal/perinatal/postpartum (puerperal, postnatal) | 120 | 4.2 | Other (e.g. Anopheles gambiae, VAR2CSA,haemozoin, malaria specific antibodies) | 15 | 0.5 |
Cord | 56 | 2.0 | Â | ||
Gravid (primigravidae, multigravidae) | 47 | 1.7 | Â | Â | Â |
CSA only | 24 | 0.8 | Â | Â | Â |
Breast milk | 20 | 0.7 | Â | Â | Â |
Diseases characteristic for pregnancy, e.g. pre-eclampsia, HELLPsyndrome | 5 | 0.2 | Â | Â | Â |